Close this search box.

Promotions at Ally Bridge

ARTICLE | Management Tracks

Plus: Schreyer named CTO at Anagenex, and updates from 4M, Sitryx and Apollomics

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst 

March 5, 2024 1:16 AM UTC

Investment firm Ally Bridge Group announced a trio of promotions: Andrew Lam to managing director, head of biotech for the firm’s private equity strategy; Slanix Paul Alex to portfolio manager and president of its public equity strategy; and Kevin Reilly to managing director, head of medtech for private equity strategy. Additionally, the company hired Zain Shekhani as managing director, head of investor relations for the firm’s private equity strategy. Shekhani was managing director at Leon Capital Group. 

Adrian Schreyer became CTO at Anagenex Inc., a drug discovery company. Schreyer was VP, AI technology at Exscientia plc (NASDAQ:EXAI). …